In this study, we found that the RBM10 expression was negatively correlated with B cells, CD8+ T cells, neutrophils, macrophages, and DC cell infiltration levels in most tumor types, indicating that RBM10 was likely to affect tumor development and prognosis by impacting the tumor microenvironment. The gene discussed is RBM10; the disease is neoplasm.